PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for APLIDIN® (plitidepsin) Covering Several Asian Countries

Posted in Local, News, World

MADRID, February 2, 2016 /PRNewswire/ —

PharmaMar (MSE:PHM) today announced an agreement with Singapore-based Specialised Therapeutics Asia Pte, Ltd (STA) to market marine-based anti-tumour compound APLIDIN® (plitidepsin) for the treatment of haematological tumours in 12 Asian countries: Brunei, Cambodia, East Timor, Indonesia, Laos, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Thailand and Vietnam.

 

• Continue Reading

TPPA won’t lead to costlier medicine, says Mustapa

Posted in Local, News

KUALA LUMPUR: The signing of the Trans-Pacific Partnership Agreement (TPPA) will not lead to an increase in the price of medicine, said International Trade and Industry Minister Datuk Seri Mustapa Mohamed.

He said the prices of pharmaceuticals were guided by various external factors.

• Continue Reading